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A B S T R A C T
DNA methylation is one of the main epigenetic modifications in the eukaryotic genome; it has been shown to
play a role in cell-type specific regulation of gene expression, and therefore cell-type identity. Bisulfite se-
quencing is the gold-standard for measuring methylation over the genomes of interest. Here, we review several
techniques used for the analysis of high-throughput bisulfite sequencing. We introduce specialized short-read
alignment techniques as well as pre/post-alignment quality check methods to ensure data quality. Furthermore,
we discuss subsequent analysis steps after alignment. We introduce various differential methylation methods and
compare their performance using simulated and real bisulfite sequencing datasets. We also discuss the methods
used to segment methylomes in order to pinpoint regulatory regions. We introduce annotation methods that can
be used for further classification of regions returned by segmentation and differential methylation methods.
Finally, we review software packages that implement strategies to efficiently deal with large bisulfite sequencing
datasets locally and we discuss online analysis workflows that do not require any prior programming skills. The
analysis strategies described in this review will guide researchers at any level to the best practices of bisulfite
sequencing analysis.
1. Introduction
Cytosine methylation (5-methylcytosine, 5mC) is one of the main
covalent base modifications in eukaryotic genomes. It is involved in
epigenetic regulation of gene expression in a cell-type specific manner.
It is reversible and can remain stable through cell division. The classical
understanding of DNA methylation is that it silences gene expression
when occurs at a CpG rich promoter region (Bock et al., 2012). It occurs
predominantly on CpG dinucleotides and seldom on non-CpG bases in
metazoan genomes. The non-CpG methylation has been mainly ob-
served in human embryonic stem and neuronal cells (Lister et al., 2009)
(Lister et al., 2013). There are roughly 28 million CpGs in the human
genome, 60–80% are generally methylated. Less than 10% of CpGs
occur in CG-dense regions that are termed CpG islands in the human
genome (Smith and Meissner, 2013). It has been demonstrated that
DNA methylation is also not uniformly distributed over the genome, but
rather is associated with CpG density. In vertebrate genomes, cytosine
bases are usually unmethylated in CpG-rich regions such as CpG islands
and tend to be methylated in CpG-deficient regions. Vertebrate
genomes are largely CpG deficient except at CpG islands. Conversely,
invertebrates such as Drosophila melanogaster and Caenorhabditis elegans
do not exhibit cytosine methylation and consequently do not have CpG
rich and poor regions but rather a steady CpG frequency over the
genome (Deaton and Bird, 2011). DNA methylation is established by
DNA methyltransferases DNMT3A and DNMT3 B in combination with
DNMT3L and maintained through/after cell division by the methyl-
transferase DNMT1 and associated proteins. DNMT3a and DNMT3b are
in charge of the de novo methylation during early development. Loss of
5mC can be achieved passively by dilution during replication or ex-
clusion of DNMT1 from the nucleus. Recent discoveries of ten-eleven
translocation (TET) family of proteins and their ability to convert 5-
methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) in verte-
brates provide a path for catalysed active DNA demethylation (Tahiliani
et al., 2009). Iterative oxidations of 5hmC catalysed by TET result in 5-
formylcytosine (5fC) and 5-carboxylcytosine (5caC). 5caC mark is ex-
cised from DNA by G/T mismatch-specific thymine-DNA glycosylase
(TDG), which as a result returns cytosine residue back to its unmodified
state (He et al., 2011). Apart from these, mainly bacteria but possibly
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higher eukaryotes contain base modifications on bases other than cy-
tosine, such as methylated adenine or guanine (Clark et al., 2011).
One of the most reliable and popular ways to measure DNA me-
thylation is bisulfite sequencing. This method, and related ones, allow
measurement of DNA methylation at the single nucleotide resolution. In
this review, we describe strategies for analyzing data from bisulfite
sequencing experiments. First, we introduce high-throughput sequen-
cing techniques based on bisulfite treatment. Next, we summarize al-
gorithms and tools for detecting differential methylation and methyla-
tion profile segmentation. Finally, we discuss management of large
datasets and data analysis workflows with a guided user interface. The
computational workflow summarizing all the necessary steps is shown
in Fig. 1.
2. Bisulfite sequencing for detection of methylation and other
base modifications
Techniques for profiling genome-wide DNA methylation fall into
four categories: methods based on restriction enzymes sensitive to DNA
methylation (such as MRE-seq), methylcytosine-specific antibodies
(such as methylated DNA immunoprecipitation using MeDIP-seq
(Weber et al., 2005)), methyl-CpG-binding domains to enrich for me-
thylated DNA at sites of interest (Brinkman et al., 2010), and those
based on sodium bisulfite treatment. However, the first three methods
allow methylation detection over measured regions ranging in size from
100 to 1000 bp. Methods that use sodium bisulfite treatment, which
converts unmethylated cytosines to thymine (via uracil) while methy-
lated cytosines remain protected, measure DNA methylation at single
nucleotide resolution (Baubec and Akalin, 2016). For the remainder of
this section, we will focus on bisulfite-conversion based sequencing
techniques.
Whole genome bisulfite sequencing (WGBS) is considered the ‘gold
standard' for assaying DNA methylation because it provides global
coverage at single-base resolution. Briefly, it combines bisulfite con-
version of DNA molecules with high-throughput sequencing. To per-
form WGBS, the genomic DNA is first randomly fragmented to the de-
sired size (200 bp). The fragmented DNA is converted into a sequencing
library by ligation to adaptors that contain 5mCs. The sequence library
is then treated with bisulfite. This treatment effectively converts un-
methylated cytosines to uracil. After amplifying the library treated with
bisulfite by PCR, it is sequenced using high-throughput sequencing.
After the PCR, uracils will be represented as thymines. A precise recall
of cytosine methylation requires not only sufficient sequencing depth,
but also strongly depends on the quality of bisulfite conversion and
library amplification. The benefit of this shotgun approach is that it
typically reaches coverage of over 90% of the CpGs in the human
genome in unbiased representation. It allows identification of non-CG
methylation as well as identification of partially methylated domains
(PMDs, (Lister et al., 2009)), and regions at distal regulatory elements
with low methylation (LMRs, (Stadler et al., 2011)) and DNA methy-
lation valleys (DMVs) in embryonic stem cells (Xie et al., 2013). Despite
its advantages, WGBS remains the most expensive technique and
standard library prep requires relatively large quantities of DNA
(100ng–5 ug); as such, it is usually not applied to large numbers of
samples (Stirzaker et al., 2014). To achieve high sensitivity in detecting
methylation differences between samples, high sequencing depth is
required which leads to significant increase in sequencing cost.
Reduced representation bisulfite sequencing (RRBS) is another
technique that can also profile DNA methylation at single-base resolu-
tion. It combines digestion of genomic DNA with restriction enzymes
and sequencing with bisulfite treatment in order to enrich for areas
with high CpG content. Thus, it relies first on digestion of genomic DNA
with restriction enzymes, such as MspI which recognises 5′-CCGG-3′
sequences and cleaves the phosphodiester bonds upstream of CpG di-
nucleotide. It can sequence only CpG dense regions and does not in-
terrogate CpG-deficient regions such as functional enhancers, intronic
regions, intergenic regions or in general lowly methylated regions
(LMRs) of the genome. It has limited coverage of the genome in CpG-
poor regions and examines about 4% to 17% of the approximately 28
million CpG dinucleotides distributed throughout the human genome
depending on the sequencing depth and which variant of RRBS is used
(Meissner et al., 2005; Rampal et al., 2014).
Targeted Bisulfite sequencing also uses a combination of bisulfite
sequencing with high-throughput sequencing, but it needs a prior
Fig. 1. Workflow for analysis of DNA me-
thylation using data from bisulfite sequen-
cing experiments.
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selection of predefined genomic regions of interest. Frequently used
protocols employ either PCR amplification of regions of interest
(Landan et al., 2012; Taylor et al., 2007), padlock probes (Ball et al.,
2009), hybridization-based target enrichment (Ivanov et al., 2013), or
convert-then-capture approaches (Li et al., 2015).
One of the major assay specific issues is the fact that bisulfite se-
quencing cannot discriminate between hydroxymethylation (5hmC)
and methylation (5mC) (Huang et al., 2010). Hydroxymethylation
converts to cyto-5-methanesulfonate upon bisulfite treatment, which
then reads as a C when sequenced (Huang et al., 2010). Furthermore,
5hmC mediated by TET proteins is a mechanism of non-passive DNA
demethylation. Hence, methylation measurements for tissues having
high 5-hydroxymethylation will be unreliable at least in certain
genomic regions. The development of Tet-assisted bisulfite sequencing
(TAB-seq) (Yu et al., 2012) and oxBS-Seq (Booth et al., 2012) has made
it possible to distinguish between the two modifications with single-
base resolution. In addition to 5hmC, single-base resolution mapping of
5caC using CAB-seq (Lu et al., 2013) and detection of 5 fc (fCAB-seq
(Song et al., 2013a; Booth et al., 2014) and redBS-Seq (Song et al.,
2013a; Booth et al., 2014)) in mammalian genomes has recently been
achieved.
3. Alignment and data processing for bisulfite sequencing
Since BS-seq changes unmethylated cytosines (C) to thymines (T),
subsequent analysis steps focus on counting the number of C to T
conversions and quantifying the methylation proportion per base. This
is simply done by identifying C-to-T conversions in the aligned reads
and dividing number of Cs by the sum of Ts and Cs for each cytosine in
the genome. Being able to do the quantification reliably depends on
quality control before alignment, the alignment methods and post-
alignment quality control.
Since base-calling quality is not constant and could change between
sequencing runs and within the same read, it is important to check the
base quality (which represents the level of confidence in the base calls).
Miscalled bases can be counted as C-T conversions erroneously, and
such errors should be avoided if possible. This basic quality check can
be done via fastQC software (http://www.bioinformatics.babraha-
m.ac.uk/projects/fastqc/). Furthermore, sometimes adapters can be
sequenced and if not properly removed, they will either lower the
alignment rates or cause false C-T conversions. We recommend trim-
ming low quality bases on sequence ends and removing adapters to
minimize issues with false C-T conversions and to increase alignment
rates. This can be achieved using trimming programs such as Trim
Galore (http://www.bioinformatics.babraham.ac.uk/projects/trim_ga-
lore/).
Once pre-alignment quality control and processing is done, the next
step is the alignment where potential C-T conversions should be han-
dled. The BS-seq alignment methods mostly rely on modifications of
known short-read alignment methods. For example, Bismark relies on
Bowtie and in silico C-T conversion of reads and genomes (Krueger and
Andrews, 2011). Many other aligners use this in silico conversion
strategy, such as: MethylCoder (Pedersen et al., 2011), BS-seeker2 (Guo
et al., 2013), BRAT-BW (Harris et al., 2012) and Bison (Ryan and
Ehninger, 2014). Other methods, such as Last (Frith et al., 2012), use a
specific score matrix that can tolerate C-T mismatches or, such as
BSMAP (Xi and Li, 2009), masks Ts in the reads and matches them to
genomic Cs. There are few comprehensive benchmarks of the aligners
since new alternatives emerge frequently, but earlier attempts to
compare the performance of the aligners did not find sufficient differ-
ences between aligners to exclude any from consideration(Tsuji and
Weng, 2016; Kunde-Ramamoorthy et al., 2014). Furthermore, recent
tools are usually only better in some aspects of the benchmark; they
may, for example, outperform competing tools in terms of computing
time, but show a much higher memory footprint or have a worse
mapping efficiency (Tsuji and Weng, 2016; Kunde-Ramamoorthy et al.,
2014). Some of these performance differences even disappear by
varying parameters of the tools (Tran et al., 2014) and we see no
compelling evidence that an established tool such as Bismark is sig-
nificantly worse or better in accuracy than competing tools. For our
own work, we frequently use Bismark since it provides BAM files, as
well as additional methylation call related metrics and files.
After the alignment and methylation calling, there is still a need for
further quality control. There are potential problems to be highlighted
here. During the end repair step following the fragmentation un-
methylated Cs are introduced at the ends of the DNA fragments (Bock,
2012). This leads to a significant drop in the average methylation level
that can be detected in a methylation bias (M-bias) plot (Bock, 2012;
Hansen et al., 2012) at those ends. A simple solution for this would be
to disregard the affected positions in the sequenced reads (Bock, 2012;
Hansen et al., 2012). Furthermore, incomplete conversion can occur
during bisulfite treatment, where not all unmethylated Cs are converted
to Ts (Genereux et al., 2008). Incomplete conversion causes false po-
sitive results due to interpretation of the unconverted unmethylated
cytosines as methylated. For species without major non-CpG methyla-
tion, such as human, we can calibrate the conversion rate by using the
percentage of non-CpG methylation. For a high quality experiment, we
expect the conversion rate to be as close to 100% as possible, typical
values for a good experiment will be higher than 99.5%. Another way to
measure conversion rate is to add spike-in sequences with un-
methylated Cs and counting the number of Ts for unmethylated Cs.
Degradation of DNA during bisulfite treatment is another potential
problem. Long incubation time and high bisulfite concentration, can
lead to the degradation of about 90% of the incubated DNA (Grunau
et al., 2001). Therefore, it is crucial to check unique alignment rates
and read lengths after trimming. Moreover, it has been shown that the
majority of CpGs with high inter-population differences contain
common genomic SNPs (minor allele frequency > 0.01) (Daca-Roszak
et al., 2015). To ensure more reliable interpretation of the data we
advise removing known C/T SNPs which can interfere with methylation
calls. The last post-alignment quality procedure addresses PCR bias. A
simple way could be to remove reads that align to the exact same
genomic position on the same strand. This de-duplication can be per-
formed using the “samtools rmdup” command or Bismark tools. For
RRBS, removing PCR duplicates by looking at overlapping coordinates
of reads is not advised. Instead, one can try to remove PCR bias by
removing regions with unusually high coverage; this method produces
concurrent methylation measurements with orthogonal methods such
as pyrosequencing (Akalin et al., 2012a).
4. Differential methylation detection methods
Once methylation proportions per base are obtained, generally, the
dynamics of methylation profiles are considered next. When there are
multiple sample groups, it is usually of interest to locate bases or re-
gions with different methylation proportions across samples. The bases
or regions with different methylation proportions across samples are
called differentially methylated CpG sites (DMCs) and differentially
methylated regions (DMRs). They have been shown to play a role in
many different diseases due to their association with epigenetic control
of gene regulation. In addition, DNA methylation profiles can be highly
tissue-specific due to their role in gene regulation (Schübeler, 2015).
DNA methylation is highly informative when studying normal and
diseased cells, because it can also act as a biomarker (Schübeler, 2015).
For example, the presence of large-scale abnormally methylated
genomic regions is a hallmark feature of many types of cancers (Ehrlich,
2002). Because of aforementioned reasons, investigating differential
methylation is usually one of the primary goals of doing bisulfite se-
quencing.
Differential DNA methylation is usually calculated by comparing the
proportion of methylated Cs in a test sample relative to a control. In
simple comparisons between such pairs of samples (i.e. test and
K. Wreczycka et al. Journal of Biotechnology 261 (2017) 105–115
107
control), methods such as Fisher’s Exact Test (implemented in e.g.
methylkit (Akalin et al., 2012b) and RnBeads (Assenov et al., 2014))
can be applied when there are no replicates for test and control cases.
There are also methods based on hidden Markov models (HMMs) such
as ComMet, included in the Bisulfighter methylation analysis suite
(Saito and Mituyama, 2015; Saito et al., 2014) or the MethPipe software
package (Song et al., 2013b). These tools are sufficient to compare one
test and one control sample at a time; if there are replicates, replicates
can be pooled within groups to a single sample per group (Akalin et al.,
2012b). This strategy, however, does not take into account biological
variability between replicates.
Regression-based methods are generally used to model methylation
levels in relation to the sample groups and variation between replicates.
Differences between currently available regression methods stem from
the choice of distribution to model the data and the variation associated
with it. In the simplest case, linear regression can be used to model
methylation per given CpG or loci across sample groups. The model fits
regression coefficients to model the expected methylation proportion
values for each CpG site across sample groups. Hence, the null hy-
pothesis of the model coefficients being zero could be tested using t-
statistics. Such models are available in the limma package (Ritchie
et al., 2015). Limma was initially developed for the detection of dif-
ferential gene expression in microarray data, but it is also used for
methylation data. It is the default method applied in RnBeads. It uses
moderated t-statistics in which standard errors have been moderated
across loci, i.e. shrunk towards a common value using Empirical Bayes
method. Another method that relies on linear regression and t-tests is
the BSmooth (Hansen et al., 2012) method. The main difference is that
BSmooth applies a local-likelihood smoother to smooth DNA methyla-
tion across CpGs within genomic windows, assumes that data follow a
binomial distribution and parameters are estimated by fitting linear
model inside windows. It calculates signal-to-noise ratio statistic similar
to t-test together with Empirical Bayes approach to test the difference
for each CpG.
However, linear regression based methods might produce fitted
methylation levels outside the range [0,1] unless the values are trans-
formed before regression. An alternative is logistic regression, which
can deal with data strictly bounded between 0 and 1 and with non-
constant variance, such as methylation proportion/fraction values. In
the logistic regression, it is assumed that fitted values have variation np
(1-p), where p is the fitted methylation proportion for a given sample
and n is the read coverage. If the observed variance is larger or smaller
than assumed by the model, one speaks of under- or overdispersion.
This over/under-dispersion can be corrected by calculating a scaling
factor and using that factor to adjust the variance estimates as in np(1-
p)s, where s is the scaling factor. MethylKit can apply logistic regression
to test the methylation difference with or without the overdispersion
correction. In this case, Chi-square or F-test can be used to compare the
difference in the deviances of the null model and the alternative model.
The null model assumes there is no relationship between sample groups
and methylation, and the alternative model assumes that there is a
relationship where sample groups are predictive of methylation values
for a given CpG or region for which the model is constructed.
More complex regression models use beta binomial distribution and
are particularly useful for better modeling the variance. Similar to lo-
gistic regression, their observation follows binomial distribution
(number of reads), but methylation proportion itself can vary across
samples, according to a beta distribution. It can deal with fitting values
in [0,1] range and performs better when there is greater variance than
expected by the simple logistic model. In essence, these models have a
different way of calculating a scaling factor when there is over-
dispersion in the model. Further enhancements are made to these
models by using the Empirical Bayes methods that can better estimate
hyperparameters of beta distribution (variance-related parameters) by
borrowing information between loci or regions within the genome to
aid with inference about each individual loci or region. Some of the
tools that rely on beta-binomial or beta model are as follows: MOABS
(Sun et al., 2014) and DSS (Feng et al., 2014), RADMeth (Dolzhenko
and Smith, 2014), BiSeq (Sun et al., 2014; Hebestreit et al., 2013) and
methylSig (Park et al., 2014).
The choice of which method to apply also depends on the data at
hand. If replicates are not available, possible tests include Fisher’s Exact
test (implemented in methylKit, RnBeads and along with many other
tool) or HMM-based methods such as ComMet. If replicates are avail-
able, tests based on regression are the natural choice rather than
pooling the sample groups. Regression methods also have the ad-
vantage that one can add covariates into the tests such as technical/
batch effects, age, sex, cell type heterogeneity, and genetic effects. For
instance, it has been shown that age is a contributing factor for me-
thylation values at some CpGs (Xu et al., 2015; Heyn et al., 2012) and
genetic heritability (McRae et al., 2014). Covariates can be added to
many methods such as methylKit, DSS, BSmooth and RnBeads.
4.1. Comparison of DMC detection methods using simulated data
Various differential methylation detection tools are based on similar
methods and each method has its own advantages and disadvantages.
To show this, we compared three classes of methods: 1) t-test/linear
regression, 2) logistic regression and 3) beta binomial regression. For
comparisons, we used both a simulated data set and a biologically re-
levant data set where we expect differentially methylated bases in
certain regions. For the simulated data set, we used three different
tools: DSS (beta binomial regression), limma (linear regression), and
methylKit (logistic regression with/without overdispersion correction).
We simulated a dataset consisting of 6 samples (3 controls and 3
samples with treatment). The read coverage modeled by a binomial
distribution. The methylation background followed a beta distribution
with parameters alpha = 0.4, beta = 0.5 and theta = 10. We simu-
lated 6 sets of 5000 CpG sites where methylation at 50% of the sites was
affected by the treatment to varying degrees − specifically, methyla-
tion was elevated by 5%, 10%, 15%, 20% and 25% with respect to the
test sample respectively. To adjust p-values for multiple testing, we
used the q-value method (Storey and Tibshirani, 2003) and we defined
differentially methylated CpG sites with q-values below 0.01 for all
examined methods. We calculated sensitivity, specificity and F-score for
each of the three methods above. Sensitivity measured the proportion
of true differentially methylated CpGs that were correctly identified as
such, specificity was calculated as the proportion of detected CpGs that
were truly not differentially methylated and correctly identified as such
and F-score refers to a way to measure sensitivity and specificity by
calculating their harmonic mean. Limma detected the fewest DMCs and
consequently the fewest true positives (see Suppl. Fig. 1) which lead to
the lowest sensitivity (Fig. 2a). DSS had similar results to limma where
both also had high specificity (Fig. 2b). MethylKit also performed well
using either the Chi-squared or F-test. MethylKit without overdispersion
showed the lowest specificity (the overdispersion correction usually
improves specificity). F-test with overdispersion has similar results to
DSS, whereas the Chi-squared test with overdispersion correction has
similar specificity to stringent methods such as DSS and limma but
achieves higher sensitivity (Fig. 2c). Overall, DSS and limma are not
very sensitive but very specific. We believe that a good compromise
between the DSS/limma/F-test and default methylKit test is the over-
dispersion corrected methylKit Chi-square test. In addition, higher ef-
fect sizes results in higher number of detected true positives, higher
sensitivity for all methods, and higher number of DMCs detected jointly
by all methods (Suppl. Fig. 2). Researchers should also consider a cutoff
for the effect size or methylation difference in their analyses, as it is
easier to detect changes with higher effect sizes and smaller effect sizes
may not be biologically meaningful. A 5% change in methylation may
not have an equivalent effect on gene expression and small changes
may be within the range of the acceptable noise for biological systems.
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4.2. Comparison of DMC detection methods using real data
The performance of different methods using simulated datasets are
always a subject of debate. There are many different ways to simulate
datasets and how the data is simulated can bias the performance me-
trics towards certain methods. Therefore, we also compared the per-
formance of different methods using real bisulfite sequencing experi-
ments where we expect to see changes between samples in certain
locations. Stadler and colleagues showed that DNA-binding factors can
create low-methylated regions upon binding (Stadler et al., 2011). One
of them, a CTCF protein, is a TF CCCTC-binding factor (zinc finger
protein) that has a critical role in complex genome processes such as
transcription, long range interactions, subnuclear organisation (Bonev
and Cavalli, 2016) and imprinting (Kurukuti et al., 2006). It had been
shown that reduced methylation is a feature of CTCF-occupied sites
supported by a high CpG content and specific CTCF recognition se-
quences, and if the site is unoccupied, the region on and around the site
will have high methylation (Maurano et al., 2015). This means that if
the CTCF occupancy changes between two cell types, we expect to see a
change in the methylation levels as well. With this information, we
looked for differentially methylated bases in regions that gained or lost
CTCF binding between two cell types. We used the CTCF occupancy
peaks supported by a presence of CTCF DNA motifs derived from the
Factorbook database, binarized as ‘peak present’ or ‘peak lost’, and the
ENCODE RRBS data (where each cell line has two replicates) for 19
human cell lines (Wang et al., 2012). We performed pairwise compar-
isons for each pair in all possible combinations of these 19 cell lines. We
defined true positives as the number of CTCF peaks gained/lost be-
tween two cell lines which overlap with at least one DMC. True nega-
tives are defined as the number of CTCF peaks that do not change be-
tween cell lines and do not overlap any DMC even though they are
covered by RRBS reads. Accordingly, false positives are defined as the
number of CTCF peaks that are present in both cell lines but overlap
with at least one DMC, while false negatives are defined as peaks that
are gained or lost between cell lines but have no DMC. We also down-
sampled the CTCF peaks that do not change to match the number of
peaks that change, in order to have a balanced classification perfor-
mance. Without this correction, true negatives overwhelm performance
metrics since there are many CTCF peaks that do not change. Differ-
entially methylated CpGs were identified for all combinations of two
cell lines using DSS, limma, methylKit and BSmooth. In the simulation
data set, we did not model changes in methylation of nearby CpGs and
since BSmooth assumes that the true methylation profile is smooth and
uses a local smoother, it was not adequate to apply this method on
simulation data and did not perform well.
For the CTCF dataset, we observed consistent results with the si-
mulated dataset results (see Fig. 3). limma has the highest specificity
(Fig. 3b), however it detects extremely small number of true positives
(Supp. Fig. 3) and has the lowest sensitivity (Fig. 3a). MethylKit without
overdispersion had the highest F-score (Fig. 3c), but also the lowest
specificity. With overdispersion, methylKit showed higher specificity
close to DSS and BSmooth and second highest F-score. methylKit and
DSS show similar methylation level of true DMCs (Fig. 3d). limma can
only capture CpGs with higher methylation difference/effect size and
BSmooth has the lowest methylation differences due to the smoothing
step performed before computing the t-statistics. Taken together with
the simulation results, methylKit without overdispersion can be used
for more exploratory analysis as it achieves higher sensitivity but lower
specificity, although it is still the best method when overall accuracy is
considered. In contrast limma, DSS and methylKit F-test with over-
dispersion correction can be applied when there is a need to limit false
positive rates, such as when picking regions or CpGs for validation. A
good compromise between stringent and relaxed methods seems to be
Chi-squared test with overdispersion correction.
Fig. 2. Comparison of DMC detection methods on simulated data. Barplots show sensitivity (a), specificity (b) and F-score (c) using DSS, limma, methylKit with Chi-squared or F-test.
Overdispersion correction available only for methylKit has a suffix “-OC”. Effect size indicates methylation differences between two groups of samples (treatment and normal samples).
Replicates in one group had elevated methylation in 50% of CpGs sites by accordingly 5%, 10%, 15%, 20% and 25%.
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4.3. Defining differentially methylated regions
Most of the methods for differential methylation calling discussed
earlier are designed to calculate both DMCs and DMRs. Some of them
are designed to detect DMRs via aggregating DMCs together within a
predefined regions, such as CpG islands or CpG shores. RADmeth
(Dolzhenko and Smith, 2014) and eDMR (Li et al., 2013) group P-values
of adjacent CpGs and produce differentially methylated regions based
on distance between differential CpGs and combination of their P-va-
lues using weighted Z-test. DSS set some thresholds on the P-values,
number of CpG sites and length of regions before aggregation. Simi-
larly, BSmooth defines DMRs by taking consecutive CpGs and cutoff
based on the marginal empirical distribution of t and DMRs are ranked
by sum of t-statistics in each CpG. BiSeq, on the other hand, first ag-
glomerates CpG sites into clusters and smoothes methylation within
clusters, uses beta regression and Wald test to test a group effect be-
tween control and test samples (with maximum likelihood with bias
reduction). Apart from the various ways of clustering nearby CpGs or
DMCs, many other methods rely on HMMs or other segmentation
methods to segment the differential CpGs into hypo- and hyper-me-
thylated regions and combine them to DMRs, such as MOABS, Meth-
pipe, ComMet and methylKit.
Other methods define DMRs directly based on pre-defined windows.
When input for functions for differential methylation calling are re-
gions, so then data is summarized per region. The regions can be either
predefined (such as regions with biological meaning like CpG islands)
or user-defined with criteria like fixed region length for tiling windows
that cover the whole genome, fixed numbers of significant adjacent CpG
sites and smoothed estimated effect sizes.
5. Segmentation of the methylome
The analysis of methylation dynamics is not exclusively restricted to
differentially methylated regions across samples, apart from this there
is also an interest in examining the methylation profiles within the same
sample. Usually, depressions in methylation profiles pinpoint reg-
ulatory regions like gene promoters that co-localize with CG-dense CpG
islands. On the other hand, many gene-body regions are extensively
methylated and CpG-poor (Bock et al., 2012). These observations would
describe a bimodal model of either hyper- or hypomethylated regions
dependent on the local density of CpGs (Lövkvist et al., 2016). How-
ever, given the detection of CpG-poor regions with locally reduced le-
vels of methylation (on average 30%) in pluripotent embryonic stem
cells and in neuronal progenitors in both mouse and human, a different
model seems also reasonable (Stadler et al., 2011). These low-methy-
lated regions (LMRs) are located distal to promoters, have little overlap
with CpG islands and associated with enhancer marks such as p300
binding sites and H3K27ac enrichment.
The identification of these LMRs can be achieved by segmentation of
the methylome using computational approaches. One of the well-
known segmentation methods is based on a three-state Hidden Markov
Model (HMM) taking only DNA methylation into account, without
knowledge of any additional genomic information such as CpG density
or functional annotations (Stadler et al., 2011). The three states that the
authors aimed for were fully methylated regions (FMRs), unmethylated
regions (UMRs) and low-methylated regions (LMRs). This segmentation
represents a summary of methylome properties and features, in which
unmethylated CpG islands correspond to UMRs (Deaton and Bird,
2011), the majority is classified as FMR since most of the genome is
methylated (Bird, 2002) and LMRs represent a new feature with in-
termediate levels of methylation, poor CpG content and shorter length
Fig. 3. Performance measurements of tools for DMCs detection based on the association between CTCF occupancy with methylation status in cell-type specific manner using the Wang
et al. data and the RRBS ENCODE data. Barplots show sensitivity (a), specificity (b) and F-score (c) using BSmooth, DSS, limma, methylKit between pairs of multiple cell lines. MethylKit
was performed using Chi-squared and F-test. MethylKit with overdispersion correction is depicted with “-OC” suffix. The absolute methylation percentage differences of DMCs found in
CTCF peaks, that for given two cell lines, in one cell line has a gain and another lost of occupancy (true positives) are shown in subfigure d.
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compared to CpG islands (Stadler et al., 2011). Other segmentation
methods such as MethPipe assume a two model state HMM and can not
differentiate between LMRs and UMRs.
The authors of the R package “MethylSeekR” (Burger et al., 2013)
adapt the idea of a three-state methylome and additionally identify
partially methylated domains (PMDs), another methylome feature
found, for instance, in human fibroblast but not in H1 embryonic stem
cells (Lister et al., 2009; Gaidatzis et al., 2014). These large regions,
spanning hundreds of kilobases, are characterized by highly disordered
methylation with average levels of methylation below 70% and cov-
ering almost 40% of the genome (Lister et al., 2009; Gaidatzis et al.,
2014). PMDs do not necessarily occur in every methylome, but their
presence can be detected using a sliding window statistic (Burger et al.,
2013). In both MethylSeekR and MethPipe, the genome wide identifi-
cation is done by training a two-state HMM, to separate PMDs from
background regions. Then the PMDs are masked prior the character-
ization of UMRs/LMRs or hyper-/hypomethylated regions (Song et al.,
2013b) (Burger et al., 2013).
There are also other segmentation strategies based on change-point
analysis, where change-points of a genome-wide signal are recorded
and the genome is partitioned into regions between consecutive change
points. This approach is typically used in the context of copy number
variation detection (Klambauer et al., 2012), but can be applied to
methylome segmentation as well.
A package implementing this method of segmentation based on
change points is methylKit. It identifies segments that are further
clustered using a mixture modeling approach. This clustering is based
on only the average methylation level of the segments and allows the
detection of distinct methylome features comparable to UMRs, LMRs
and FMRs. This approach provides a more robust approach to seg-
mentation where one can decide on the number of segmentation classes
after segmentation. Whereas in HMM-based methods, one must know, a
priori, the number of segmentation classes or run multiple rounds of
HMMs with different numbers and identify which model fits best to the
data.
5.1. Comparison of segmentation methods
We compared the change-point based segmentation to
MethylSeekR, the latter of which is partially based on HMMs but mainly
using cutoffs for methylation values. We identified high-concordance
between these two methods by analysing chromosome 2 of the H1
embryonic stem cell methylome from the Roadmap Epigenomics
Project (Kundaje et al., 2015). They describe regions with similar seg-
ment lengths, number of CpGs per segment, methylation values and
genome annotation (Fig. 4a–d, respectively).
We also applied change-point based segmentation to a genome with
PMDs. We segmented the Human IMR90 methylome from the Roadmap
Epigenomics Project (Kundaje et al., 2015) into four distinct features
using methylKit. Then we compared feature-specific properties to
published PMDs identified with MethPipe (Song et al., 2013b) (Lister
et al., 2009; Gaidatzis et al., 2014), (Fig. 5a–c) and found the feature
with mean methylation level of segments closest to 50% to be the most
proximate. We overlapped the published regions with all segments of
this feature and found that 94% of the published regions of PMDs
overlap with the generated segments of our feature (Fig. 5d).
In summary, change-point-based methods can be useful in the seg-
mentation of the methylome, they provide classifications comparable to
HMMs and also identify PMDs.
6. Strategies for dealing with large datasets
With rising numbers of publicly available epigenetic data, it is
tempting to reconstruct the results of published papers for many rea-
sons, e.g. to better understand the reasoning behind steps the authors
took or to develope a general intuition for the data. In the case of
bisulfite sequencing data, we might want to perform differential me-
thylation analysis in R using whole genome methylation data of mul-
tiple samples. The problem is that for genome-wide experiments, file
sizes can easily range from hundreds of megabytes to gigabytes and
processing multiple instances of those files in memory (RAM) might
become infeasible unless we have access to a high performance cluster
(HPC) with extensive RAM. If we want to use a desktop computer or
laptop with limited RAM, we either need to restrict our analysis to a
subset of the data or use packages that can handle this situation.
The authors of the RADmeth package for differential methylation
analysis advise running the software on a “computing cluster with a few
hundred available nodes” to allow the processing of multiple WGBS
samples in a reasonable time. The same analysis can also be performed
on a personal workstation with the disadvantage of increasing the
computation time, which is in general dependent on three factors: the
sample coverage, the number of sites analyzed and the number of
samples. There exists one avenue to speed up the time-consuming step
of regression if one’s workstation is a multicore system. The authors
included a script to split the input data into smaller pieces which could
than be processed separately and merged afterwards using UNIX com-
mands.
A package for the comprehensive analysis of genome-wide DNA
methylation data that can handle large data is RnBeads (Assenov et al.,
2014), which internally relies on the ‘ff’ package. The R package ‘ff’
(Adler et al., 2014) allows work with datasets larger than available
RAM by storing them as temporary files and providing an interface to
enable reading and writing from flat files and operate on the parts that
have been loaded into R.
The methylKit package provides very similar capability by ex-
ploiting flat file databases to substitute in-memory objects if the objects
grow too large. The internal data apart from meta information has a
tabular structure storing chromosome, start/end position, strand in-
formation of the associated CpG base just like many other biological
formats like BED, GFF or SAM. By exporting this tabular data into a
TAB-delimited file and making sure it is accordingly position-sorted it
can be indexed using the generic Tabix tool (Lövkvist et al., 2016). In
general “Tabix indexing is a generalization of BAM indexing for generic
TAB-delimited files. It inherits all the advantages of BAM indexing,
including data compression and efficient random access in terms of few
seek function calls per query.” (Li, 2011). MethylKit relies on Rsamtools
(http://bioconductor.org/packages/release/bioc/html/Rsam-
tools.html) which implements tabix functionality for R and this way
internal methylKit objects can be efficiently stored as compressed file
on the disk and still be fast accessed. Another advantage is that existing
compressed files can be loaded in interactive sessions, allowing the
backup and transfer of intermediate analysis results.
7. Annotation of DMRs/DMCs and segments
The regions of interest obtained through differential methylation or
segmentation analysis often need to be integrated with genome anno-
tation datasets. Without this type of integration, differential methyla-
tion or segmentation results will be hard to interpret in biological
terms. The most common annotation task is to see where regions of
interest land in relation to genes and gene parts and regulatory regions:
Do they mostly occupy promoter, intronic or exonic regions? Do they
overlap with repeats? Do they overlap with other epigenomic markers
or long-range regulatory regions? These questions are not specific to
methylation −nearly all regions of interest obtained via genome-wide
studies have to deal with such questions. Thus, there are already mul-
tiple software tools that can produce such annotations. One is the
Bioconductor package genomation (Akalin et al., 2015). It can be used
to annotate DMRs/DMCs and it can also be used to integrate methy-
lation proportions over the genome with other quantitative information
and produce meta-gene plots or heatmaps. Another similar package is
ChIPpeakAnno (Zhu et al., 2010), which is designed for ChIP-seq peak
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annotation but could also be used for DMR/DMC annotation to a certain
degree.
8. Workflows and tools that do not require programming
experience
Software packages for the analysis of whole genome bisulfite se-
quencing data perform computationally intensive tasks and are there-
fore hosted on advanced hardware infrastructures. Moreover, the ma-
jority of the tools require programming knowledge (e.g. writing R
commands). If the local execution of those tools is not feasible due to
insufficient processing power or expertise, using an online service could
be an alternative. For example, an analysis workflow on the RnBeads
web service is started by simply uploading the data and setting a
handful of options through a web form. The limitations it imposes on
file size, however, make it infeasible for large datasets. Galaxy is an
open source, web-based platform for data intensive biomedical research
(see https://galaxyproject.org), providing access to publicly available
servers and tools dedicated to data processing and analysis. A curated
list of tools exists at https://toolshed.g2.bx.psu.edu hosting 4300 dif-
ferent programs for use within Galaxy at the time of writing, including
methylKit https://toolshed.g2.bx.psu.edu/view/rnateam/methylkit/
a8705df7c57f) and RnBeads (https://toolshed.g2.bx.psu.edu/view/
pavlolutsik/rnbeads/6b0981ab063e).
WBSA is another freely available2 web service for WGBS and RRBS
(http://wbsa.big.ac.cn/) data. It is a modular collection of custom
scripts combined with widely used tools, such as BWA for alignment
and FastQC for quality control. The focus of WBSA is on ease of use.
Uploading data and setting up analysis parameters is achieved using a
small web form. The main advantages of this service are support for
genome assemblies from 10 species, support for a range of sequencing
protocols, as well as extraction and analysis of non-CpG methylation.
More flexibility can be achieved by downloading and locally installing
the modules, however, installing the WBSA back-end is a non-trivial
task as its long list of dependencies includes tools and libraries from
heterogeneous platforms: Java, MySQL, Perl, and R.
9. Conclusions
In this review, we have discussed the experimental and the com-
putational methods for measuring and analysing DNA methylation in a
genome-wide or targeted manner. We presented all the necessary steps
of downstream analysis for bisulfite sequencing experiments starting
from read alignment and quality check. We discussed and compared
differential methylation and methylome segmentation methods. Our
efforts for comparing differential methylation methods revealed that
performances of different methods are comparable. One can choose
methods based on the overall goal of their research. The methods that
are stringent and limit the false positive rates are good for subsequent
validation studies (DSS, limma, BSmooth, MethylKit with F-test and
overdispersion correction), however these methods sacrifice sensitivity
(true positive rate) for the sake of reducing false positives. A very re-
laxed method, such as the default methylKit method, has the best ac-
curacy overall but highest false positive rate. A good alternative to
stringent and relaxed methods is Chi-square test after overdispersion
correction (implemented in methylKit). This method has high sensi-
tivity without sacrificing too much for specificity. For segmentation
methods, we observed high-concordance between cutoff-based methods
and change-point analysis based methods. Change-point analysis
methods are more flexible in the sense that they identify multiple
Fig. 4. Comparison of features identified by segmentation tools analysing chromosome 2 of the H1 embryonic stem cells methylome. Boxplots show for each feature the distribution of (a)
segment lengths in log10 transformed base pairs (bp) (b) CpG position covered by each segment in log10 transformed numbers (c) average methylation score per segment. (a) − (c)
Boxplot colors indicate the tool generating the features either methylKit or MethylSeekR. (d) Heatmap showing the percentage of methylSeeker and methylKit segments that overlapped
with chromatin state annotations for H1 embryonic stem cells.
2 for academic use only.
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biologically relevant segments within the same analysis. For example,
HMM or cutoff based methods should first remove partially methylated
domains (PMDs) from the analysis in order to define LMRs. Whereas
methods based on change-point analysis can identify LMRs and PMDs in
the same step.
We believe with this guideline of methods for BS-seq analysis both
bioinformaticians and experimental biologists will gain insight into ex-
perimental design as well as best practises for computational analysis. The
code that we used to generate the results is available online on the website:
https://github.com/BIMSBbioinfo/Strategies_for_analyzing_BS-seq
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